ERGIC2
ERGIC and golgi 2
Summary
ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).[supplied by OMIM, Aug 2008]
Known Variants24 total
| rsid | Position (GRCh37) | Alleles | Class | ClinVar |
|---|---|---|---|---|
| rs1183309670 | 12:29,494,099 | T/C | — | uncertain significance |
| rs375534310 | 12:29,494,671 | T/C | — | uncertain significance |
| rs368454190 | 12:29,494,678 | G/A | — | uncertain significance |
| rs2498372864 | 12:29,496,073 | C/T | — | uncertain significance |
| rs372266940 | 12:29,496,103 | T/C | — | uncertain significance |
| rs1422147471 | 12:29,496,193 | G/T | — | uncertain significance |
| rs10843390 | 12:29,496,991 | C/T | downstream gene variant | — |
| rs753461147 | 12:29,498,387 | C/T | — | likely benign |
| rs747854922 | 12:29,498,417 | T/C | — | uncertain significance |
| rs2498383465 | 12:29,502,024 | T/C | — | uncertain significance |
| rs2498383554 | 12:29,502,068 | T/G | — | uncertain significance |
| rs10082956 | 12:29,504,556 | A/G | intron variant | — |
| rs755870893 | 12:29,509,403 | C/T | — | uncertain significance |
| rs1035606 | 12:29,509,450 | C/T | intron variant | — |
| rs371850211 | 12:29,510,577 | G/A | — | uncertain significance |
| rs200037116 | 12:29,510,578 | T/C | — | likely benign |
| rs760860114 | 12:29,519,821 | C/G | — | uncertain significance |
| rs1443477632 | 12:29,519,880 | T/A | — | uncertain significance |
| rs10128781 | 12:29,520,706 | T/C | intron variant | — |
| rs371837303 | 12:29,521,198 | T/C | — | uncertain significance |
| rs367724085 | 12:29,523,048 | T/C | — | uncertain significance |
| rs563896541 | 12:29,523,117 | T/C | — | uncertain significance |
| rs1156242 | 12:29,523,957 | T/C | intron variant | — |
| rs9651802 | 12:29,525,436 | T/G | intron variant | — |
Gene information from NCBI Gene. Variant classifications from ClinVar.